ClinVar Miner

Submissions for variant NM_178857.6(RP1L1):c.133C>T (p.Arg45Trp)

gnomAD frequency: 0.00001  dbSNP: rs267607017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000726920 SCV000704172 likely pathogenic not provided 2016-12-21 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000002277 SCV000916218 uncertain significance Occult macular dystrophy 2017-08-22 criteria provided, single submitter clinical testing The RP1L1 c.133C>T (p.Arg45Trp) missense variant has been reported in at least six studies and is found in a heterozygous state in a total of 35 individuals with occult macular dystrophy, including 15 unrelated individuals. The variant is also found in 13 unaffected family members (Akahori et al. 2010; Okuno et al. 2013; Hayashi et al. 2012; Davidson et al. 2013; Piermarocchi et al. 2016; Fujinami al. 2016). Due to the presence of both affected and unaffected family members carrying the p.Arg45Trp variant in a heterozygous state, Akahori et al. (2010) and Davidson et al. (2013) suggest that the variant may exhibit reduced penetrance or later age of onset in asymptomatic carriers. The p.Arg45Trp variant was absent from 976 controls but is reported at a frequency of 0.000025 in the total population of the Genome Aggregation Database. Based on the evidence, the p.Arg45Trp variant is classified a variant of unknown significance but suspicious for pathogenicity for occult macular dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Blueprint Genetics RCV001074376 SCV001239954 pathogenic Retinal dystrophy 2019-07-30 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000726920 SCV001245752 likely pathogenic not provided 2023-10-01 criteria provided, single submitter clinical testing RP1L1: PP1:Strong, PS4:Moderate, PM2:Supporting
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001197672 SCV001368451 pathogenic Retinitis pigmentosa 88 2019-12-03 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PP1-S,PP3.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000726920 SCV001447606 likely pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Invitae RCV000726920 SCV001585398 pathogenic not provided 2024-01-02 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 45 of the RP1L1 protein (p.Arg45Trp). This variant is present in population databases (rs267607017, gnomAD 0.01%). This missense change has been observed in individuals with autosomal dominant occult macular dystrophy (PMID: 20826268, 30025130). It has also been observed to segregate with disease in related individuals. This variant is also known as c.362C>T. ClinVar contains an entry for this variant (Variation ID: 2193). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RP1L1 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV000726920 SCV001770569 pathogenic not provided 2022-12-01 criteria provided, single submitter clinical testing Reduced penetrance has been reported for the p.(R45W) variant (Zobor et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23281133, 34440443, 32458067, 25908487, 23619761, 26782618, 22466457, 29555955, 28890726, 27579568, 35464678, 32360662, 32176261, 30025130, 20826268, 22504327, 23745001, 27623337, 28195981, 31028767, 31193770, 32940107, 32531858)
Institute of Human Genetics, University of Leipzig Medical Center RCV000002277 SCV001976392 uncertain significance Occult macular dystrophy 2022-03-16 criteria provided, single submitter clinical testing _x000D_ Criteria applied: PS4_MOD, PP3
MGZ Medical Genetics Center RCV000002277 SCV002580293 likely pathogenic Occult macular dystrophy 2021-11-18 criteria provided, single submitter clinical testing
OMIM RCV000002277 SCV000022435 risk factor Occult macular dystrophy 2013-03-01 no assertion criteria provided literature only
Clinical Genetics, Academic Medical Center RCV000726920 SCV001922196 pathogenic not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000726920 SCV001955747 likely pathogenic not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000726920 SCV001975316 likely pathogenic not provided no assertion criteria provided clinical testing
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein RCV000002277 SCV002011783 likely pathogenic Occult macular dystrophy 2021-08-26 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.